Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 178

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 178
---
 Natwest Markets the investment banking division
of Natwest Bank in the U.K. He began his career at Drexel Burnham where he was an Executive Vice President running the global equity division
as well as being on the Executive Committee. Mr. Kirsch has served on the Board of Kadmon since 2019, a publicly traded bio pharmaceutical
company where he serves on the Audit Committee. He also serves on the board of Liquidia Technologies a public nano technology healthcare
company as well as being the Chairman of the Audit Committee. Mr. Kirsch received his B.A. in Finance from the University of Rhode Island
and an M.B.A. from Bernard M. Baruch College.

Mark Dant.Mr. Dant, EveryLife Foundation
for Rare Diseases Board Chair, is a parent advocate and retired Carrolton, Texas Police Department Chief of Police. Mark and his wife
Jeanne are the parents of Ryan, who is 33 years old and the longest treated person in the world with MPS I. Mark and Jeanne spearheaded
the funding for the first MPS Enzyme Replacement Therapy, Aldurazyme, through their Foundation, the Ryan Foundation. In partnership with
Dr. Emil Kakkis, Mr. Dant and his family were also key advocates speaking to the FDA about the importance and significant impact of ERT
for the treatment of mucopolysaccharidoses. In 2009, Mr. Dant and his family successfully championed Congress to pass the Ryan Dant Health
Care Opportunity Act, H.R. 1441-111.

Family Relationships

There are no family relationships
among any of our officers or directors, except that Christer Rosén, our Chairman of the Board and Chief Executive Officer, is the
father of Alexander Rosén, our Chief Administrative Officer.

Involvement in Certain Legal Proceedings

No executive officer, member
of the board of directors or control person of our Company has been involved in any legal proceeding listed in Item 401(f) of Regulation
S-K in the past 10 years.

Corporate Governance

Board Leadership Structure and Board’s Role in Risk Oversight

We have not separated the
positions of Chairman of the Board and Chief Executive Officer. Christer Rosén has served as our Chairman of the Board of Directors
and Chief Executive Officer since January 1, 2016. We believe that combining the positions of Chairman and Chief Executive Officer allows
for focused leadership of our organization which benefits us in our relationships with investors,